Controlling patient temperature is important for a wide variety of clinical conditions. Cooling to normal or below normal body temperature is often performed for neuroprotection after ischemic insult (e.g. hemorrhagic stroke, subarachnoid hemorrhage, cardiac arrest, or other hypoxic injury). Cooling from febrile states treats fever and reduces the negative effects of hyperthermia on injured neurons. Patients are warmed in the operating room to prevent inadvertent perioperative hypothermia, which is known to cause increased blood loss, wound infections, and myocardial injury, while also prolonging recovery time. There are many reported approaches for temperature management, including improvised methods that repurpose standard supplies (e.g., ice, chilled saline, fans, blankets) but more sophisticated technologies designed for temperature management are typically more successful in delivering an optimized protocol. Over the last decade, advanced technologies have developed around two heat transfer methods: surface devices (water blankets, forced-air warmers) or intravascular devices (sterile catheters requiring vascular placement). Recently, a novel device became available that is placed in the esophagus, analogous to a standard orogastric tube, that provides efficient heat transfer through the patient's core. The device connects to existing heat exchange units to allow automatic patient temperature management via a servo mechanism, using patient temperature from standard temperature sensors (rectal, Foley, or other core temperature sensors) as the input variable. This approach eliminates vascular placement complications (deep venous thrombosis, central line associated bloodstream infection), reduces obstruction to patient access, and causes less shivering when compared to surface approaches. Published data have also shown a high degree of accuracy and maintenance of target temperature using the esophageal approach to temperature management. Therefore, the purpose of this method is to provide a low-risk alternative method for controlling patient temperature in critical care settings.
Introduction
There is significant need for patient temperature management when treating a wide range of conditions, including cardiac arrest, refractory or recurrent fever, neurogenic fever, and major surgery. In the United States, a half-million cardiac arrests annually originate either in the hospital (for example, in patients who are undergoing care for general medical or surgical conditions) 1 or out of the hospital (for example, at home or in public venues, who are then brought to the emergency department) 2 . In both scenarios, patient outcomes are significantly improved when active temperature management is administered 3 and targeted temperature management (TTM) has been a standard of care for cardiac arrest since 2005. Over 5 million patients are admitted to intensive care units annually in the U.S 4 . Of these, fever develops in up to 45% of nonneurologically injured patients 5 and up to 70% of neurologically injured patients 6 . Fever control in the intensive care unit is associated with improved outcomes and reduced risk of death, because elevated temperature increases metabolic demands, worsens cerebral ischemia, and increases neuronal loss 7 . At least 10 million surgeries performed annually in the U.S. require active patient warming to prevent inadvertent perioperative hypothermia 8 .
The esophageal approach to patient temperature management offers substantial advantages to existing technologies 18 . The esophageal temperature management device maintains the functionality of the gastric tube typically placed in the critical care and surgical patient populations. It allows continuous gastric suction and decompression of gas and liquids while adding the ability to control a patient's temperature safely and efficiently by leveraging the favorable heat exchange environment of the esophagus (Figure 1) . Temperature modulation is achieved by connecting the esophageal temperature management device to any of several external heat exchangers (also called chillers) that use water as the coolant. Several vendors produce compatible heat exchangers that are available in hospitals for powering existing temperature control products (most often water blankets). Nurses, nurse practitioners, or physicians typically place an esophageal temperature management device, but it can also be inserted by any provider trained to place a standard orogastric tube. The esophageal temperature management device does not restrict access to the patient, need not be sterile, avoids the risk of needle stick injuries among providers, and avoids the risks of skin complications, bloodstream infections, and blood clots in the patient. Therefore, the purpose of this method is to provide a low-risk alternative method for controlling patient temperature in critical care and operating room settings. 
Assessment Guidelines Prior to Placement
NOTE: Although there are no formal contraindications listed in the U.S. labelling, it is recommended that the esophageal temperature management device be used with caution in patients with known esophageal deformity, evidence of esophageal trauma, and in patients known to have ingested acidic or caustic poisons within the prior 24 hours.
1. Obtain all equipment, including appropriate heat exchange unit, the esophageal temperature management device, an appropriate securement device, water-based lubrication packets, and a circumferential bite block. 2. Place Foley thermistor and/or rectal temperature probe and connect one to the heat exchange unit. A second temperature source is recommended for verification, and may be connected to the patient monitor. 3. Connect the esophageal temperature management device to the appropriate heat exchanger, power on the unit, set the patient target temperature according to hospital protocol, and place the heat exchanger in automatic mode. Ensure that water is flowing through the esophageal temperature management device and confirm that no leaks are present.
Device Insertion
1. Measure the appropriate insertion depth for the esophageal temperature management device by extending it from the patient's lips to the earlobe and then from the earlobe to the tip of the xiphoid process; mark the insertion depth on the device (Figure 2 ). 
Representative Results

Aggregate Data
In terms of cooling, maintenance, and warming rates, esophageal temperature management performs similarly to other advanced temperature management technologies. An analysis of 30 patients treated for up to 36 hours with esophageal temperature management found that the average time to temperature was 2.7 h (SD ±2.8 h) and that 96% of temperature readings recorded during the maintenance period were within ±1 °C 19 . Performance was consistent across all protocols, regardless of target temperature ( Figure 5, Figure 6, Figure 7, Figure 8 ). Performance remained consistent with treatment durations longer than 72 h (Figure 9 and Figure 10 ).
Notable Cases
Numerous case studies describe the application of esophageal temperature management in practice, including for the treatment of post cardiac arrest ischemia-reperfusion injury, central fever reduction, and maintenance of operative normothermia 20, 21, 22, 23, 24, 25, 26, 27 . Though the esophageal temperature management method was initially conceived in the context of cardiac arrest treatment, the following cases highlight its successful translation into other critical care and perioperative domains.
Case 1: Meningitis
A 36 year-old woman with a weight of 64 kg was admitted with severe Streptococcus pyrogenes meningitis. Her body temperature increased from 38.2 °C on admission to 40.0 °C six hours later; IV acetaminophen and external cooling blankets proved unsuccessful to adequately decrease temperature.
The esophageal temperature management was initiated at 48 h and the patient's temperature dropped from 39.4 °C to 37.8 °C in 4 hours. The patient's temperature continued to drop towards 36.6 °C during the next 12 hours and was maintained between 36 °C and 37 °C for 5 days. Gastroscopy on day 7 revealed no changes attributable to the esophageal temperature management device.
Case 2: Severe Burn and Pyrexia Reversal
A 49 year-old male weighing 86 kg was admitted with 49% circumferential burns that included full thickness burns to both legs, left arm, and left torso. Two days after admission, the patient was brought to the operating room for surgical procedures that included staged excision and grafting of the leg wounds. Upon placing the esophageal temperature management device and initiating temperature management, the patient's core temperature was maintained at normothermia while allowing the operating suite temperature to be decreased successfully to 24°C
. Subsequently, on day 22 of the patient's hospitalization, the patient developed a fever due to E. coli and Candida septicemia resistant to conventional cooling methods. Esophageal temperature management was again initiated, reducing the patient's temperature from 40 °C to the set point of 38.5 °C, and this temperature was maintained despite restricting the minimum allowable water temperature to 12 °C. 
Discussion
Modification and troubleshooting required for this protocol is generally limited to that featured above, and involves the typical monitoring of patient care employed in critical care settings. Modulating core temperature is critical to patient outcomes in a growing range of clinical scenarios. These include the intentional induction of hypothermia from normothermia, rewarming from inadvertent or intentional hypothermia, and actively maintaining normal body temperature (i.e., normothermia) during conditions in which inadvertent hypothermia are common, such as in the operating room. As specific clinical examples, patients who suffer ischemia-reperfusion injury, such as occurs during cardiac arrest, benefit from cooling (generally to temperatures below normal body temperature) followed by gentle rewarming and fever prevention for up to 3 days after resuscitation 28, 29, 30 . Neonates suffering from hypoxic ischemic encephalopathy obtain improved outcomes if cooled below normal body temperature 31 . The cooling of kidney donors after neurologic death, prior to organ transplant, has been shown to reduce the rate of delayed graft function 32 . Controlling fevers in septic shock patients may reduce vasopressor requirements and contribute to reducing early mortality 33 . Maintaining normothermia in patients undergoing surgical procedures reduces surgical wound infections, myocardial complications, blood loss, and transfusion requirements, while shortening length of stay and reducing the likelihood of death 10, 11, 16 .
Limitations of the technique include challenges encountered in managing critical care patients. While targeted temperature management promotes good outcomes, the most common temperature modulation techniques introduce risks to patients and logistical challenges to providers (including difficulties in placement, bloodstream infections, blood clots, skin damage, and cost). Esophageal temperature management is designed to overcome these shortcomings 34, 35, 36 . When appropriately managed, the esophageal temperature management device does not come into contact with the vasculature (as do the intravascular temperature modulation devices) or skin (as do the surface temperature modulation devices), thereby avoiding blood clots, bloodstream infection, and skin degradation. The device can be placed quickly by a variety of healthcare providers, typically in a matter of minutes 21, 37 
